消化管間質腫瘍（GIST）治療の世界市場（～2026年）

• 英文タイトル：Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY12011 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料は消化管間質腫瘍（GIST）治療のグローバル市場について調査・分析したレポートです。種類別（手術、標的療法、放射線療法、化学療法、アブレーション、塞栓術、その他）市場規模、用途別（病院、クリニック、外来手術センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別消化管間質腫瘍（GIST）治療の競争状況、市場シェア ・世界の消化管間質腫瘍（GIST）治療市場：種類別市場規模 2015年-2020年（手術、標的療法、放射線療法、化学療法、アブレーション、塞栓術、その他） ・世界の消化管間質腫瘍（GIST）治療市場：種類別市場規模予測 2021年-2026年（手術、標的療法、放射線療法、化学療法、アブレーション、塞栓術、その他） ・世界の消化管間質腫瘍（GIST）治療市場：用途別市場規模 2015年-2020年（病院、クリニック、外来手術センター、その他） ・世界の消化管間質腫瘍（GIST）治療市場：用途別市場規模予測 2021年-2026年（病院、クリニック、外来手術センター、その他） ・北米の消化管間質腫瘍（GIST）治療市場分析：米国、カナダ ・ヨーロッパの消化管間質腫瘍（GIST）治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの消化管間質腫瘍（GIST）治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の消化管間質腫瘍（GIST）治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの消化管間質腫瘍（GIST）治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer、Bayer、Novartis、Immunicum、Roche、AB Science、Arog Pharmaceuticals、Boston Biomedical、Sun Pharmaceutical、Natco Pharma ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

A Gastrointestinal Stromal Tumor (GIST) is a type of tumor which occurs in the gastrointestinal tract and most commonly in the stomach or small intestine.

Market Analysis and Insights: Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market
The global Gastrointestinal Stromal Tumors (GISTs) Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Gastrointestinal Stromal Tumors (GISTs) Treatment Scope and Market Size
Gastrointestinal Stromal Tumors (GISTs) Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Gastrointestinal Stromal Tumors (GISTs) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Pfizer
Bayer
Novartis
Immunicum
Roche
AB Science
Arog Pharmaceuticals
Boston Biomedical
Sun Pharmaceutical
Natco Pharma

Market segment by Type, the product can be split into
Surgery
Targeted Therapy
Radiation Therapy
Chemotherapy
Ablation
Embolization
Others
Market segment by Application, split into
Hospitals
Clinics
Ambulatory Surgical Centers
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Gastrointestinal Stromal Tumors (GISTs) Treatment Revenue
1.4 Market by Type
1.4.1 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Surgery
1.4.3 Targeted Therapy
1.4.4 Radiation Therapy
1.4.5 Chemotherapy
1.4.6 Ablation
1.4.7 Embolization
1.4.8 Others
1.5 Market by Application
1.5.1 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Ambulatory Surgical Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Perspective (2015-2026)
2.2 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Growth Trends by Regions
2.2.1 Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Gastrointestinal Stromal Tumors (GISTs) Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Gastrointestinal Stromal Tumors (GISTs) Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Gastrointestinal Stromal Tumors (GISTs) Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Gastrointestinal Stromal Tumors (GISTs) Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Gastrointestinal Stromal Tumors (GISTs) Treatment Players by Market Size
3.1.1 Global Top Gastrointestinal Stromal Tumors (GISTs) Treatment Players by Revenue (2015-2020)
3.1.2 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Concentration Ratio
3.2.1 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Gastrointestinal Stromal Tumors (GISTs) Treatment Revenue in 2019
3.3 Gastrointestinal Stromal Tumors (GISTs) Treatment Key Players Head office and Area Served
3.4 Key Players Gastrointestinal Stromal Tumors (GISTs) Treatment Product Solution and Service
3.5 Date of Enter into Gastrointestinal Stromal Tumors (GISTs) Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Historic Market Size by Type (2015-2020)
4.2 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2015-2020)
5.2 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size (2015-2020)
6.2 Gastrointestinal Stromal Tumors (GISTs) Treatment Key Players in North America (2019-2020)
6.3 North America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type (2015-2020)
6.4 North America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size (2015-2020)
7.2 Gastrointestinal Stromal Tumors (GISTs) Treatment Key Players in Europe (2019-2020)
7.3 Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type (2015-2020)
7.4 Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2015-2020)

8 China
8.1 China Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size (2015-2020)
8.2 Gastrointestinal Stromal Tumors (GISTs) Treatment Key Players in China (2019-2020)
8.3 China Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type (2015-2020)
8.4 China Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size (2015-2020)
9.2 Gastrointestinal Stromal Tumors (GISTs) Treatment Key Players in Japan (2019-2020)
9.3 Japan Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type (2015-2020)
9.4 Japan Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size (2015-2020)
10.2 Gastrointestinal Stromal Tumors (GISTs) Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2015-2020)

11 India
11.1 India Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size (2015-2020)
11.2 Gastrointestinal Stromal Tumors (GISTs) Treatment Key Players in India (2019-2020)
11.3 India Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type (2015-2020)
11.4 India Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size (2015-2020)
12.2 Gastrointestinal Stromal Tumors (GISTs) Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type (2015-2020)
12.4 Central & South America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Gastrointestinal Stromal Tumors (GISTs) Treatment Introduction
13.1.4 Pfizer Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Bayer
13.2.1 Bayer Company Details
13.2.2 Bayer Business Overview
13.2.3 Bayer Gastrointestinal Stromal Tumors (GISTs) Treatment Introduction
13.2.4 Bayer Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2015-2020)
13.2.5 Bayer Recent Development
13.3 Novartis
13.3.1 Novartis Company Details
13.3.2 Novartis Business Overview
13.3.3 Novartis Gastrointestinal Stromal Tumors (GISTs) Treatment Introduction
13.3.4 Novartis Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2015-2020)
13.3.5 Novartis Recent Development
13.4 Immunicum
13.4.1 Immunicum Company Details
13.4.2 Immunicum Business Overview
13.4.3 Immunicum Gastrointestinal Stromal Tumors (GISTs) Treatment Introduction
13.4.4 Immunicum Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2015-2020)
13.4.5 Immunicum Recent Development
13.5 Roche
13.5.1 Roche Company Details
13.5.2 Roche Business Overview
13.5.3 Roche Gastrointestinal Stromal Tumors (GISTs) Treatment Introduction
13.5.4 Roche Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2015-2020)
13.5.5 Roche Recent Development
13.6 AB Science
13.6.1 AB Science Company Details
13.6.2 AB Science Business Overview
13.6.3 AB Science Gastrointestinal Stromal Tumors (GISTs) Treatment Introduction
13.6.4 AB Science Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2015-2020)
13.6.5 AB Science Recent Development
13.7 Arog Pharmaceuticals
13.7.1 Arog Pharmaceuticals Company Details
13.7.2 Arog Pharmaceuticals Business Overview
13.7.3 Arog Pharmaceuticals Gastrointestinal Stromal Tumors (GISTs) Treatment Introduction
13.7.4 Arog Pharmaceuticals Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2015-2020)
13.7.5 Arog Pharmaceuticals Recent Development
13.8 Boston Biomedical
13.8.1 Boston Biomedical Company Details
13.8.2 Boston Biomedical Business Overview
13.8.3 Boston Biomedical Gastrointestinal Stromal Tumors (GISTs) Treatment Introduction
13.8.4 Boston Biomedical Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2015-2020)
13.8.5 Boston Biomedical Recent Development
13.9 Sun Pharmaceutical
13.9.1 Sun Pharmaceutical Company Details
13.9.2 Sun Pharmaceutical Business Overview
13.9.3 Sun Pharmaceutical Gastrointestinal Stromal Tumors (GISTs) Treatment Introduction
13.9.4 Sun Pharmaceutical Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2015-2020)
13.9.5 Sun Pharmaceutical Recent Development
13.10 Natco Pharma
13.10.1 Natco Pharma Company Details
13.10.2 Natco Pharma Business Overview
13.10.3 Natco Pharma Gastrointestinal Stromal Tumors (GISTs) Treatment Introduction
13.10.4 Natco Pharma Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2015-2020)
13.10.5 Natco Pharma Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Gastrointestinal Stromal Tumors (GISTs) Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Gastrointestinal Stromal Tumors (GISTs) Treatment Revenue
Table 3. Ranking of Global Top Gastrointestinal Stromal Tumors (GISTs) Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Surgery
Table 6. Key Players of Targeted Therapy
Table 7. Key Players of Radiation Therapy
Table 8. Key Players of Chemotherapy
Table 9. Key Players of Ablation
Table 10. Key Players of Embolization
Table 11. Key Players of Others
Table 12. Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Regions (2015-2020)
Table 16. Global Gastrointestinal Stromal Tumors (GISTs) Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Gastrointestinal Stromal Tumors (GISTs) Treatment Market Growth Strategy
Table 22. Main Points Interviewed from Key Gastrointestinal Stromal Tumors (GISTs) Treatment Players
Table 23. Global Gastrointestinal Stromal Tumors (GISTs) Treatment Revenue by Players (2015-2020) (Million US$)
Table 24. Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Players (2015-2020)
Table 25. Global Top Gastrointestinal Stromal Tumors (GISTs) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment as of 2019)
Table 26. Global Gastrointestinal Stromal Tumors (GISTs) Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Gastrointestinal Stromal Tumors (GISTs) Treatment Product Solution and Service
Table 29. Date of Enter into Gastrointestinal Stromal Tumors (GISTs) Treatment Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type (2015-2020) (Million US$)
Table 32. Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size Share by Type (2015-2020)
Table 33. Global Gastrointestinal Stromal Tumors (GISTs) Treatment Revenue Market Share by Type (2021-2026)
Table 34. Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size Share by Application (2015-2020)
Table 35. Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2015-2020) (Million US$)
Table 36. Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size Share by Application (2021-2026)
Table 37. North America Key Players Gastrointestinal Stromal Tumors (GISTs) Treatment Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share (2019-2020)
Table 39. North America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type (2015-2020) (Million US$)
Table 40. North America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Type (2015-2020)
Table 41. North America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2015-2020) (Million US$)
Table 42. North America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Application (2015-2020)
Table 43. Europe Key Players Gastrointestinal Stromal Tumors (GISTs) Treatment Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share (2019-2020)
Table 45. Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Type (2015-2020)
Table 47. Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Application (2015-2020)
Table 49. China Key Players Gastrointestinal Stromal Tumors (GISTs) Treatment Revenue (2019-2020) (Million US$)
Table 50. China Key Players Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share (2019-2020)
Table 51. China Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type (2015-2020) (Million US$)
Table 52. China Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Type (2015-2020)
Table 53. China Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2015-2020) (Million US$)
Table 54. China Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Application (2015-2020)
Table 55. Japan Key Players Gastrointestinal Stromal Tumors (GISTs) Treatment Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share (2019-2020)
Table 57. Japan Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Type (2015-2020)
Table 59. Japan Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Gastrointestinal Stromal Tumors (GISTs) Treatment Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share (2019-2020)
Table 63. Southeast Asia Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Type (2015-2020)
Table 65. Southeast Asia Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Application (2015-2020)
Table 67. India Key Players Gastrointestinal Stromal Tumors (GISTs) Treatment Revenue (2019-2020) (Million US$)
Table 68. India Key Players Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share (2019-2020)
Table 69. India Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type (2015-2020) (Million US$)
Table 70. India Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Type (2015-2020)
Table 71. India Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2015-2020) (Million US$)
Table 72. India Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Gastrointestinal Stromal Tumors (GISTs) Treatment Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share (2019-2020)
Table 75. Central & South America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Type (2015-2020)
Table 77. Central & South America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Application (2015-2020)
Table 79. Pfizer Company Details
Table 80. Pfizer Business Overview
Table 81. Pfizer Product
Table 82. Pfizer Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2015-2020) (Million US$)
Table 83. Pfizer Recent Development
Table 84. Bayer Company Details
Table 85. Bayer Business Overview
Table 86. Bayer Product
Table 87. Bayer Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2015-2020) (Million US$)
Table 88. Bayer Recent Development
Table 89. Novartis Company Details
Table 90. Novartis Business Overview
Table 91. Novartis Product
Table 92. Novartis Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2015-2020) (Million US$)
Table 93. Novartis Recent Development
Table 94. Immunicum Company Details
Table 95. Immunicum Business Overview
Table 96. Immunicum Product
Table 97. Immunicum Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2015-2020) (Million US$)
Table 98. Immunicum Recent Development
Table 99. Roche Company Details
Table 100. Roche Business Overview
Table 101. Roche Product
Table 102. Roche Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2015-2020) (Million US$)
Table 103. Roche Recent Development
Table 104. AB Science Company Details
Table 105. AB Science Business Overview
Table 106. AB Science Product
Table 107. AB Science Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2015-2020) (Million US$)
Table 108. AB Science Recent Development
Table 109. Arog Pharmaceuticals Company Details
Table 110. Arog Pharmaceuticals Business Overview
Table 111. Arog Pharmaceuticals Product
Table 112. Arog Pharmaceuticals Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2015-2020) (Million US$)
Table 113. Arog Pharmaceuticals Recent Development
Table 114. Boston Biomedical Business Overview
Table 115. Boston Biomedical Product
Table 116. Boston Biomedical Company Details
Table 117. Boston Biomedical Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2015-2020) (Million US$)
Table 118. Boston Biomedical Recent Development
Table 119. Sun Pharmaceutical Company Details
Table 120. Sun Pharmaceutical Business Overview
Table 121. Sun Pharmaceutical Product
Table 122. Sun Pharmaceutical Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2015-2020) (Million US$)
Table 123. Sun Pharmaceutical Recent Development
Table 124. Natco Pharma Company Details
Table 125. Natco Pharma Business Overview
Table 126. Natco Pharma Product
Table 127. Natco Pharma Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2015-2020) (Million US$)
Table 128. Natco Pharma Recent Development
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Type: 2020 VS 2026
Figure 2. Surgery Features
Figure 3. Targeted Therapy Features
Figure 4. Radiation Therapy Features
Figure 5. Chemotherapy Features
Figure 6. Ablation Features
Figure 7. Embolization Features
Figure 8. Others Features
Figure 9. Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Application: 2020 VS 2026
Figure 10. Hospitals Case Studies
Figure 11. Clinics Case Studies
Figure 12. Ambulatory Surgical Centers Case Studies
Figure 13. Others Case Studies
Figure 14. Gastrointestinal Stromal Tumors (GISTs) Treatment Report Years Considered
Figure 15. Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 16. Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Regions: 2020 VS 2026
Figure 17. Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Regions (2021-2026)
Figure 18. Porter's Five Forces Analysis
Figure 19. Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Players in 2019
Figure 20. Global Top Gastrointestinal Stromal Tumors (GISTs) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment as of 2019
Figure 21. The Top 10 and 5 Players Market Share by Gastrointestinal Stromal Tumors (GISTs) Treatment Revenue in 2019
Figure 22. North America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. China Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Japan Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Southeast Asia Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. India Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Central & South America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Bottom-up and Top-down Approaches for This Report
Figure 30. Data Triangulation
Figure 31. Key Executives Interviewed

---